Skip to main content
Clinical Trials/NCT02943512
NCT02943512
Unknown
Not Applicable

Same Day Discharge

University of Cincinnati1 site in 1 country40 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Arrhythmia
Sponsor
University of Cincinnati
Enrollment
40
Locations
1
Primary Endpoint
Average number of late complications between the 2 arms
Last Updated
9 years ago

Overview

Brief Summary

This study is to assess if subjects receiving a clinically indicated implanted cardiac pacemaker or defibrillator can be safely discharge home the same day of the procedure.

Detailed Description

Subjects who are implanted with a clinically indicated implanted cardiac pacemaker or defibrillator will be randomized to standard of care (next day discharge) versus same day discharge post implant. Both groups will under go standard of care assessments prior to discharge. The same day discharge group will receive a phone call the next day to assess for events and will transmit device data electronically. Both groups will be seen 10 - 14 days after implant for further evaluation. The subjects will also complete questionnaires regarding their knowledge of self care and satisfaction with care.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
December 2018
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alexandru Costea

Principal Investigator

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • Scheduled for clinically indicated implant of cardiac pacemaker or defibrillator
  • Willing and able to provide informed consent
  • Appropriate clinical indication for the purpose of this study
  • Primary prevention implantable cardioverter-defibrillator implant indicated for sudden cardiac death with ejection fraction more than 20%
  • Sick sinus syndrome, non-high degree heart block as indication for pacemaker implant.
  • No history of syncope
  • No documented sudden cardiac death or ventricular arrhythmias requiring shock
  • Adequate social support to be able to comply with protocol.
  • Ability to complete remote monitor transmission

Exclusion Criteria

  • Determined to be at risk for bleeding or on oral anticoagulation
  • Planned to be implanted with non-Biotronik device
  • Complete heart block as indication for permanent pacemaker
  • Secondary ICD indication
  • Immediate procedural complication requiring prolonged admission such as: pneumothorax, large hematoma, tamponade) determined during the procedure or immediately before discharge.

Outcomes

Primary Outcomes

Average number of late complications between the 2 arms

Time Frame: up to 2 weeks after procedure

Study Sites (1)

Loading locations...

Similar Trials